NEW YORK (GenomeWeb) – NeoGenomics today reported a 26 percent year-over-year increase in first quarter revenues, including a 14 percent rise in testing revenue. 

For the three months ended March 31, the Ft. Myers, Fla.-based cancer genetics testing company posted $23 million in revenues, up from $18.2 million in the year-ago quarter. During the recently completed quarter, NeoGenomics performed 49,396 tests for $20.7 million in testing revenues, compared to 38,734 million tests and $18.2 million in testing revenues in the year-ago period. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.